Evidence Hub

Patent foramen ovale-management challenges: a case series

Alma Sijamija, Nermir Granov, Alma Agačević, Omer Perva, Nedžad Hadžić

Cardiologia Croatica, 2017

Abstract

1Travnik General Hospital, Travnik, Bosnia and Herzegovina 2Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina KeYWORdS: patent foramen ovale, management. citAtiON: Cardiol Croat. 2019;14(3-4):92-3. | https://doi.org/10.15836/ccar2019.92 *AddReSS FOR cORReSPONdeNce: Alma Sijamija, J.U. Bolnica Travnik, Kalibunar bb, 72270 Travnik, Bosna and Herzegovina. / Phone: +387-61-780-085 / E-mail: [email protected] ORcid: Alma Sijamija, http://orcid.org/0000-0003-2818-0501 • Nermir Granov, http://orcid.org/0000-0002-6228-6230 Alma Agačević, http://orcid.org/0000-0003-4671-0991 • Omer Perva, http://orcid.org/0000-0003-2645-1558 Nedžad Hadžić, http://orcid.org/0000-0002-7186-7803

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free